TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,504
|
4,517
|
4,583 |
| Financial expenses |
93
|
167
|
117 |
| Earnings before taxes |
12
|
-49
|
-60 |
| EBITDA |
513
|
617
|
557 |
| Total assets |
2,345
|
2,351
|
2,755 |
| Current assets |
1,400
|
895
|
801 |
| Current liabilities |
556
|
399
|
755 |
| Equity capital |
354
|
343
|
391 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
15.1%
|
14.6%
|
14.2% |
| Turnover per employee |
4,504
|
4,517
|
2,292 |
| Profit as a percentage of turnover |
0.3%
|
-1.1%
|
-1.3% |
| Return on assets (ROA) |
4.5%
|
5.0%
|
2.1% |
| Current ratio |
251.8%
|
224.3%
|
106.1% |
| Return on equity (ROE) |
3.4%
|
-14.3%
|
-15.3% |
| Change turnover |
-13
|
-66
|
13 |
| Change turnover % |
0%
|
-1%
|
0% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.